Albemarle Corporation
Albemarle Reports Third Quarter 2025 Results with Net Loss and Improved EBITDA
Summary
Albemarle Corporation announced its third-quarter 2025 financial results, reporting a net loss of $161 million or $1.72 per diluted share, but with adjusted EBITDA up by 6.7% to $226 million due to cost and productivity improvements. The company's net sales slightly decreased to $1.3 billion, down 3.5% year-over-year. Albemarle also announced plans to sell stakes in Ketjen and the Eurecat joint venture for combined pre-tax proceeds of approximately $660 million, enhancing its financial flexibility and outlook for the full year 2025.
Get alerts for ALB
Be first to know when Albemarle Corporation files with the SEC.
Filing Categories
Advertisement
About Albemarle Corporation
Albemarle Corporation is a global leader in the chemical manufacturing industry, specializing in the production of lithium, bromine, and catalysts. As a significant player in the lithium market, Albemarle is integral to the rapidly growing electric vehicle (EV) sector, owing to lithium's essential role in battery production. The company's operations extend across diverse applications, from energy storage solutions to petroleum refining and the pharmaceuticals industry. By providing advanced materials and solutions, Albemarle plays a crucial role in enabling cleaner energy technologies and sustainable industrial practices. Headquartered in Charlotte, North Carolina, Albemarle operates on a global scale, with production facilities and research centers strategically located around the world. The company's commitment to innovation and sustainability ensures its continuous impact on emerging technologies, making it a crucial stakeholder in the transition towards more sustainable energy and advanced industrial processes. Albemarle's market significance is underscored by its strategic partnerships and global supply chains that support some of the most dynamic and essential sectors in today's economy.
Official SEC Documents
Advertisement